Scleroderma Research Grant Program - Established Investigator Award

Scleroderma Research Grant Program - Established Investigator Award

Funder: National Scleroderma Foundation Inc (MA, US)
Website: scleroderma.org

Overview

The National Scleroderma Foundation's peer-reviewed research grant program provides funding to established investigators conducting scleroderma research. Award amount increased to $200,000 per grant (increased from $150,000) effective for the 2022 grant funding cycle.

Geographic Scope

• United States

Focus Areas

• Scleroderma research with priority in:
- Scleroderma-related lung disease research - Pediatric scleroderma - Basic and clinical science

Program Details

• Merit-based peer review: Uses the same merit-based scoring system as the National Institutes of Health
• Review committee: Comprised of medical and research experts from across the United States
• Success rate: Approximately 30-33% of applications funded
• Total annual funding commitment: $2.723 million (as of FY 2022)
• Historical commitment: Foundation has committed more than $30 million to advancing medical research in scleroderma since inception in 1998

Eligibility

• Established investigators conducting scleroderma research
• Open to researchers at institutions throughout the United States

Application Requirements

• Annual peer review process
• All funded recipients must submit annual progress reports
• Reports reviewed by Research Committee for compliance with programmatic, scientific, and fiscal/administrative policies

Contact Information

• Address: 55 Ferncroft Road Suite #315, Danvers, MA 01923
• Phone: (800) 722-4673 or (978) 624-1243
• Email: info@scleroderma.org
• Website: scleroderma.org